From Formation to Exit - Legal Strategy Across the Biotech Lifecycle

Session details:

The legal choices a biotech company makes early on can define its long-term trajectory. From licensing structures and board formation to equity allocation, IP positioning, and investor rights. This panel brings together legal and business leaders to explore how early-stage companies prepare for scale, navigate inflection points, and position themselves for eventual exits through acquisition, IPO, or strategic partnerships.

Key Topics:

• How foundational legal strategy sets the stage for future funding and partnering flexibility
• Common missteps in early company setup that create friction during diligence or deal structuring
• The evolving expectations of investors and acquirers around control terms, licensing, and governance
• How BD, legal, and finance functions align at each stage of growth